S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Boredom, loneliness plague Ukrainian youth near front line
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Is AMC Entertainment Pulling a Fast One on the APEs?
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Saudi Aramco's profits already $88B as oil prices stay high
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Boredom, loneliness plague Ukrainian youth near front line
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Is AMC Entertainment Pulling a Fast One on the APEs?
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Saudi Aramco's profits already $88B as oil prices stay high
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Boredom, loneliness plague Ukrainian youth near front line
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Is AMC Entertainment Pulling a Fast One on the APEs?
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Saudi Aramco's profits already $88B as oil prices stay high
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Boredom, loneliness plague Ukrainian youth near front line
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
Is AMC Entertainment Pulling a Fast One on the APEs?
High oil prices help Saudi Aramco earn $88B in first half
Ship carrying grain for hungry Ethiopia leaves Ukraine
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
Here is a Simple 4 Stock Portfolio that Can Outperform the Market
Saudi oil company Aramco's half-year profits reach close to $88 billion after posting a 90% surge in second quarter
Saudi Aramco's profits already $88B as oil prices stay high
Sick of seeing others get rich in the stock market? Let Stock Advisor help (Ad)
OTCMKTS:AUGX

Augmedix - AUGX Stock Forecast, Price & News

$1.57
-0.09 (-5.42%)
(As of 08/12/2022 09:14 PM ET)
Add
Compare
Today's Range
$1.45
$1.69
50-Day Range
$1.48
$2.05
52-Week Range
$1.41
$6.22
Volume
138,900 shs
Average Volume
32,687 shs
Market Capitalization
$58.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.63

Augmedix MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
258.3% Upside
$5.63 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.70mentions of Augmedix in the last 14 days
Based on 7 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.62) to ($0.50) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.90 out of 5 stars

About Augmedix

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Receive AUGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter.

AUGX Stock News Headlines

Augmedix Reports Second Quarter 2022 Financial Results
Augmedix (OTCMKTS:AUGX) Price Target Cut to $4.50
Augmedix (NASDAQ:AUGX), Short Interest Report
Augmedix reports Q4 results
Augmedix Announces New Board Member, Laurie McGraw
See More Headlines
Receive AUGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter.

AUGX Company Calendar

Last Earnings
8/09/2021
Today
8/14/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:AUGX
Fax
N/A
Employees
706
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.63
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$4.50
Forecasted Upside/Downside
+258.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$-17,850,000.00
Pretax Margin
-77.52%

Debt

Sales & Book Value

Annual Sales
$22.17 million
Book Value
$0.64 per share

Miscellaneous

Free Float
N/A
Market Cap
$58.73 million
Optionable
Not Optionable
Beta
-1.01

Key Executives

  • Mr. Emmanuel Krakaris (Age 63)
    Pres, CEO, Sec. & Director
    Comp: $683.54k
  • Mr. Ian Shakil (Age 37)
    Founder, Chief Strategy Officer & Director
  • Ms. Sandra Breber (Age 64)
    Chief Operating Officer
    Comp: $429.15k
  • Mr. Saurav Chatterjee Ph.D. (Age 50)
    Chief Technology Officer
    Comp: $415.4k
  • Mr. Paul Louis Ginocchio (Age 52)
    Chief Financial Officer
  • Todd Holvick
    Head of Legal & Compliance
  • Lia Wallick
    Head of People
  • Dr. Davin Lundquist M.D.
    Chief Medical Officer
  • Mr. Jonathan Hawkins (Age 52)
    Chief Revenue Officer













AUGX Stock - Frequently Asked Questions

Should I buy or sell Augmedix stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Augmedix in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AUGX shares.
View AUGX analyst ratings
or view top-rated stocks.

What is Augmedix's stock price forecast for 2022?

5 brokerages have issued 12 month target prices for Augmedix's shares. Their AUGX share price forecasts range from $4.50 to $6.00. On average, they expect the company's share price to reach $5.63 in the next year. This suggests a possible upside of 258.3% from the stock's current price.
View analysts price targets for AUGX
or view top-rated stocks among Wall Street analysts.

How have AUGX shares performed in 2022?

Augmedix's stock was trading at $3.15 at the beginning of 2022. Since then, AUGX stock has decreased by 50.2% and is now trading at $1.57.
View the best growth stocks for 2022 here
.

How were Augmedix's earnings last quarter?

Augmedix, Inc. (OTCMKTS:AUGX) announced its quarterly earnings results on Monday, August, 9th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.19) by $0.02. The firm earned $5.17 million during the quarter, compared to analyst estimates of $5.18 million. Augmedix had a negative trailing twelve-month return on equity of 251.74% and a negative net margin of 77.52%.

What is Augmedix's stock symbol?

Augmedix trades on the OTCMKTS under the ticker symbol "AUGX."

Who are Augmedix's major shareholders?

Augmedix's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Millrace Asset Group Inc. (2.43%), Perkins Capital Management Inc. (1.17%), Russell Investments Group Ltd. (0.88%) and TownSquare Capital LLC (0.73%).

How do I buy shares of Augmedix?

Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Augmedix's stock price today?

One share of AUGX stock can currently be purchased for approximately $1.57.

How much money does Augmedix make?

Augmedix (OTCMKTS:AUGX) has a market capitalization of $58.73 million and generates $22.17 million in revenue each year. The company earns $-17,850,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis.

How many employees does Augmedix have?

The company employs 706 workers across the globe.

How can I contact Augmedix?

The official website for the company is www.augmedix.com. The company can be reached via phone at 888-669-4885 or via email at investors@augmedix.com.

This page (OTCMKTS:AUGX) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.